Recently, similar median OS data were reported in studies from Tissot et al. (16 months) [35] and Ding et al. (14.7 months) [36] in Stage IV BRAF V600E-mutant metastatic NSCLC. Here, BRAF is linked to non-small cell lung carcinoma.